Myriam Witvrouw
Rega Institute for Medical Research
Katholieke Universiteit Leuven
Belgium
Name/email consistency: high
- Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Witvrouw, M., Pannecouque, C., Switzer, W.M., Folks, T.M., De Clercq, E., Heneine, W. Antivir. Ther. (Lond.) (2004)
- Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry. Witvrouw, M., Pannecouque, C., Fikkert, V., Hantson, A., Van Remoortel, B., Hezareh, M., De Clercq, E., Brown, S.J. Antivir. Chem. Chemother. (2003)
- Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. Witvrouw, M., Fikkert, V., Pluymers, W., Matthews, B., Mardel, K., Schols, D., Raff, J., Debyser, Z., De Clercq, E., Holan, G., Pannecouque, C. Mol. Pharmacol. (2000)
- 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. Witvrouw, M., Arranz, M.E., Pannecouque, C., Declercq, R., Jonckheere, H., Schmit, J.C., Vandamme, A.M., Diaz, J.A., Ingate, S.T., Desmyter, J., Esnouf, R., Van Meervelt, L., Vega, S., Balzarini, J., De Clercq, E. Antimicrob. Agents Chemother. (1998)
